Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroblastoma today.

A Ferster1, R Schots, R Maurus

  • 1Oncologie Pédiatrique, Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes Specialist Nurses' Experiences of Supporting Emerging Adults Living With Type 1 Diabetes Mellitus After the Transfer to Adult Care-A Qualitative Study.

Nursing research and practice·2026
Same author

Spermatogenesis after gonadotoxic childhood treatment: follow-up of 12 patients.

Human reproduction open·2023
Same author

Effect of the New Nordic Diet compared with usual care on glucose control in gestational diabetes mellitus: Study protocol for the randomized controlled trial intervention with new Nordic DIet in women with GestatiOnal diabetes mellitus (iNDIGO).

Contemporary clinical trials·2022
Same author

Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol.

European journal of cancer (Oxford, England : 1990)·2021
Same author

CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2021
Same author

Effective rescue treatment with vemurafenib of an infant with high-risk Langerhans cell histiocytosis.

Annales de dermatologie et de venereologie·2020
Same journal

Tumor microenvironment-mediated interactions between macrophages and cancer cells define immunoregulatory transcriptional programs.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Photocontrol of zebrafish behavior with a photoswitchable ligand of nicotinic acetylcholine receptors.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Corrigendum to "Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization" [Biomed. Pharmacother. 141 (2021) 111883].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Corrigendum to "Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)" [Biomed. Pharmacother. 200 (2026), 119609].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
See all related articles

Despite advances in diagnosis and treatment, the prognosis for children over one year old with advanced neuroblastoma remains poor. Novel therapeutic strategies show promise in improving response rates and disease-free survival, but long-term outcomes require further study.

Area of Science:

  • Pediatric Oncology
  • Cancer Therapeutics
  • Medical Diagnostics

Background:

  • Neuroblastoma diagnosis and staging have improved with advances in radiology, nuclear medicine, immunohematology, and genetics.
  • Despite new cytostatic drugs, the prognosis for children over one year old with advanced neuroblastoma remains poor.

Purpose of the Study:

  • To evaluate the impact of novel therapeutic refinements on neuroblastoma treatment outcomes.
  • To assess the effectiveness of multiagent regimens, high-dose chemotherapy, autologous bone marrow transplantation, and total body irradiation in improving patient survival.

Main Methods:

  • Review of current therapeutic strategies for advanced neuroblastoma.
  • Analysis of treatment outcomes including response rate, disease-free survival, and long-term survival.

Related Experiment Videos

  • Consideration of adjunct therapies such as immunomagnetic purging and total body irradiation.

    • Main Results:

    • Advanced therapeutic regimens, including high-dose chemotherapy with autologous bone marrow transplantation, have improved response rates and disease-free survival in metastatic neuroblastoma patients.
    • The efficacy of these intensive treatments on long-term survival is yet to be fully determined.

    Conclusions:

    • While current intensive therapies enhance short-term outcomes for advanced neuroblastoma, further research is crucial to establish their long-term survival benefits.
    • Continued investigation into novel therapeutic approaches is necessary to improve the overall prognosis for pediatric neuroblastoma patients.